Scholars Central

Conference abstract

Building a robust oncology clinical research program in the community-based setting

Authors: Lora Black

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Although 85% of cancer patients in the United States are treated within the community-based setting, opportunities for advanced treatment options via clinical trials are lacking. The National Comprehensive Cancer Network (NCCN) Guidelines state ???NCCN believes that the best management for any patient with cancer is a clinical trial. Participation in clinical trials is especially encouraged??? (NCCN 2018). To address the need for clinical trials in the rural communities served by Sanford Health, efforts described here were employed over the last five years to develop and maintain a robust portfolio of clinical trials for physicians to utilize as innovative treatment options. Successful approaches to cultivating an oncology clinical research program include (but are not limited to): developing a relationship with clinical operations, administration, physicians, support staff, research staff, and external partners. Formal trial selection through a protocol review and monitoring committee ensures physician engagement in the process of building a trial portfolio, and assists the study team in identifying feasibility concerns at the outset of considering the trial at the site. Furthermore, leveraging efficiencies of an integrated health care system are critical for study-start up, data collection, and subject coordination ??? all of which contribute to a site???s ongoing ability to remain attractive for future site selection. In addition, utilizing existing infrastructure for patient care management to screen eligible patients for trial significantly increases institutional enrollment percentages. The complexities of a clinical trial program focused in oncology are wide and varied. However, building a program is not impossible as long as the appropriate commitment, strategy, and dedication of resources are applied. Recent Publications 1. Powell S, Dib E, Bleeker J, Keppen M, Mazurczak M, Hack K, Gitau M, Steen P, Terstriep S, Reynolds J, Landsverk M, Chan C H, Nelson M, Thompson P, Ellison C, Black L, Ford J, Chung J, Anhorn R and Gaba A (2018) Delivering precision oncology in a community cancer program: results from a prospective observational study. Journal of Clinical Oncology, Precision Oncology. DOI: 10.1200/PO.17.00220. 2. Ersek J, Black L, Thompson M and Kim E (2018) Implementing precision medicine programs and clinical trials in the community-based oncology practice: barriers and best practices. ASCO (American Society of Clinical Oncology) Educational Book DOI: 10.1200/EDBK_200633. 3. Powell S, Gitau M, Spanos W, Jensen A, Nowak R, Lohr M, Puumala S, Ellison C, Black L, Cheng J, Sacco A, Cohen E and Lee J (2016) Phase IB study of pembrolizumab in combination with chemoradiotherapy (CRT) for locally-advanced squamous cell carcinoma of the head and neck (LA-SCCHN). Journal of Clinical Oncology 34(15).

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Clinical Research & Bioethics.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical Research & Bioethics
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Lora Black”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels